66 related articles for article (PubMed ID: 21235903)
21. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.
Dickinson CD; Shobe J; Ruf W
J Mol Biol; 1998 Apr; 277(4):959-71. PubMed ID: 9545384
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of human factor VIIa/tissue factor in complex with peptide mimetic inhibitor.
Kadono S; Sakamoto A; Kikuchi Y; Oh-eda M; Yabuta N; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
Biochem Biophys Res Commun; 2004 Nov; 324(4):1227-33. PubMed ID: 15504346
[TBL] [Abstract][Full Text] [Related]
23. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor.
Girard TJ; Warren LA; Novotny WF; Likert KM; Brown SG; Miletich JP; Broze GJ
Nature; 1989 Apr; 338(6215):518-20. PubMed ID: 2927510
[TBL] [Abstract][Full Text] [Related]
24. Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
Huang H; Norledge BV; Liu C; Olson AJ; Edgington TS
Biochemistry; 2003 Sep; 42(36):10619-26. PubMed ID: 12962485
[TBL] [Abstract][Full Text] [Related]
25. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
26. Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity.
Jin J; Chang J; Chang JY; Kelley RF; Stafford DW; Straight DL
Biochemistry; 1999 Jan; 38(4):1185-92. PubMed ID: 9930978
[TBL] [Abstract][Full Text] [Related]
27. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
Iakhiaev A; Ruf W; Rao LV
Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
[TBL] [Abstract][Full Text] [Related]
28. Peptide exosite inhibitors of factor VIIa as anticoagulants.
Dennis MS; Eigenbrot C; Skelton NJ; Ultsch MH; Santell L; Dwyer MA; O'Connell MP; Lazarus RA
Nature; 2000 Mar; 404(6777):465-70. PubMed ID: 10761907
[TBL] [Abstract][Full Text] [Related]
29. The solution structure of human coagulation factor VIIa in its complex with tissue factor is similar to free factor VIIa: a study of a heterodimeric receptor-ligand complex by X-ray and neutron scattering and computational modeling.
Ashton AW; Boehm MK; Johnson DJ; Kemball-Cook G; Perkins SJ
Biochemistry; 1998 Jun; 37(22):8208-17. PubMed ID: 9609717
[TBL] [Abstract][Full Text] [Related]
30. Solution structure of the N-terminal EGF-like domain from human factor VII.
Muranyi A; Finn BE; Gippert GP; Forsén S; Stenflo J; Drakenberg T
Biochemistry; 1998 Jul; 37(30):10605-15. PubMed ID: 9692950
[TBL] [Abstract][Full Text] [Related]
31. Ancylostoma ceylanicum anticoagulant peptide-1: role of the predicted reactive site amino acid in mediating inhibition of coagulation factors Xa and VIIa.
Mieszczanek J; Harrison LM; Cappello M
Mol Biochem Parasitol; 2004 Sep; 137(1):151-9. PubMed ID: 15279961
[TBL] [Abstract][Full Text] [Related]
32. Tissue Factor/Factor FVII Complex Inhibitors in Cardiovascular Disease. Are Things Going Well?
Petrillo G; Cirillo P; D'Ascoli GL; Maresca F; Ziviello F; Chiariello M
Curr Cardiol Rev; 2010 Nov; 6(4):325-32. PubMed ID: 22043208
[TBL] [Abstract][Full Text] [Related]
33. Allosteric regulation of the cofactor-dependent serine protease coagulation factor VIIa.
Ruf W; Dickinson CD
Trends Cardiovasc Med; 1998 Nov; 8(8):350-6. PubMed ID: 14987549
[TBL] [Abstract][Full Text] [Related]
34. In Silico Design of Novel Anticoagulant Peptides targeting Blood Coagulation Factor VIIa.
Al-Amri MS; Alrasadi K; Bayoumi R; Banerjee Y
Sultan Qaboos Univ Med J; 2011 Feb; 11(1):83-94. PubMed ID: 21509213
[TBL] [Abstract][Full Text] [Related]
35. Modeling the distribution of enzymes on lipid vesicles: A novel framework for surface-mediated reactions in coagulation.
Madrigal J; Monroe DM; Sindi SS; Leiderman K
Math Biosci; 2024 Jun; 374():109229. PubMed ID: 38851530
[TBL] [Abstract][Full Text] [Related]
36. Tissue factor structure and function.
Butenas S
Scientifica (Cairo); 2012; 2012():964862. PubMed ID: 24278763
[TBL] [Abstract][Full Text] [Related]
37. Correction to: Direct Amplification of Tissue Factor:Factor VIIa Procoagulant Activity by Bile Acids Drives Intrahepatic Coagulation.
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):e312. PubMed ID: 33085524
[No Abstract] [Full Text] [Related]
38. Correction to "Atropisomer Control in Macrocyclic Factor VIIa Inhibitors".
Glunz PW; Mueller L; Cheney DL; Ladziata V; Zou Y; Wurtz NR; Wei A; Wong PC; Wexler RR; Priestley ES
J Med Chem; 2018 Apr; 61(8):3752. PubMed ID: 29620363
[No Abstract] [Full Text] [Related]
39. Reversible Coagulation in Living Tissue: X.
Bancroft WD; Gutsell RS; Rutzler JE
Proc Natl Acad Sci U S A; 1932 Jan; 18(1):8-15. PubMed ID: 16577433
[No Abstract] [Full Text] [Related]
40. Molecular and structural advances in tissue factor-dependent coagulation.
Kirchhofer D; Banner DW
Trends Cardiovasc Med; 1997 Nov; 7(8):316-24. PubMed ID: 21235903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
